Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.
about
Review article: esomeprazole in the treatment of Helicobacter pylori.Antagonist: population based endoscopic screening for colorectal cancer.A review of recent randomized trials in colorectal disease.Colorectal cancers soon after colonoscopy: a pooled multicohort analysisOption appraisal of population-based colorectal cancer screening programmes in England.Korean guidelines for postpolypectomy colonoscopy surveillance.Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy.Methods to Estimate the Comparative Effectiveness of Clinical Strategies that Administer the Same Intervention at Different Times.Population screening for colorectal cancer: the implications of an ageing population.Colonoscopy for screening and follow up of patients with a family history of colorectal cancer.The impact of fair colonoscopy preparation on colonoscopy use and adenoma miss rates in patients undergoing outpatient colonoscopy.Colorectal cancer: current care, future innovations and economic considerations.Influence of long-term colonoscopic surveillance on incidence of colorectal cancer and death from the disease in patients with precursors (adenomas).Patient attitudes towards faecal immunochemical testing for haemoglobin as an alternative to colonoscopic surveillance of groups at increased risk of colorectal cancer.A deterministic model for estimating the reduction in colorectal cancer incidence due to endoscopic surveillance.
P2860
Q34669301-80A73CB9-F3D3-434E-9899-E594EC8051E4Q35065314-76B8C567-9168-4F4D-97FD-13974C885313Q35142641-B94CF342-12A6-42D7-A9AE-9BC15EE9DF3DQ35249785-62575895-5E3A-4D3C-8A45-898000E42716Q35929500-7D9CF6AA-7BEC-4C25-8E1D-0C51E3F05ADBQ35997255-278596D2-17B6-4A94-BFEF-56B0956EFD8EQ36130196-465BA825-3CF5-4E43-9281-89C394A7126DQ36283253-DE03F889-84E6-4C96-BB6A-52548DB7BA7BQ37023866-A4E435C1-51A7-4703-B229-A9CDE3ADB071Q37101670-A32A4D75-41B3-4822-96A9-17903B5AF010Q37342974-68F76763-6758-4475-8F33-C75A5D1D7F56Q37763182-539EE78B-70B4-4007-B768-3B9252049945Q38462815-45FDA9C9-E29D-4842-B6F9-C2240B175B1EQ43620135-BC70E922-122D-441B-95CC-7A3DB76D27B8Q44773446-BFC8BBEB-A0FE-4042-89D9-ECEE46F4106D
P2860
Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Risks, costs, and compliance l ...... ssons from a randomised trial.
@ast
Risks, costs, and compliance l ...... ssons from a randomised trial.
@en
type
label
Risks, costs, and compliance l ...... ssons from a randomised trial.
@ast
Risks, costs, and compliance l ...... ssons from a randomised trial.
@en
prefLabel
Risks, costs, and compliance l ...... ssons from a randomised trial.
@ast
Risks, costs, and compliance l ...... ssons from a randomised trial.
@en
P2093
P2860
P356
P1433
P1476
Risks, costs, and compliance l ...... essons from a randomised trial
@en
P2093
J H Scholefield
M H Robinson
N C Armitage
P2860
P356
10.1136/GUT.49.1.91
P407
P577
2001-07-01T00:00:00Z